Insights

Gathering insights about Cingulate Therapeutics…

Similar companies to Cingulate Therapeutics

Cingulate Therapeutics Tech Stack

Cingulate Therapeutics uses 8 technology products and services including Module Federation, Web Vitals, DataTables, and more. Explore Cingulate Therapeutics's tech stack below.

Module Federation
Development
Web Vitals
Javascript Libraries
DataTables
Javascript Libraries
core-js
Javascript Libraries
PHP
Programming Languages
HSTS
Security
X-Content-Type-Options
Web & Portal Technology
Google Analytics
Web Analytics

Media & News

Cingulate Therapeutics's Email Address Formats

Cingulate Therapeutics uses at least 2 format(s):

Cingulate Therapeutics Email Formats	Example	Percentage
FLast@cingulatetherapeutics.com	JDoe@cingulatetherapeutics.com	80%
First.Last@cingulatetherapeutics.com	John.Doe@cingulatetherapeutics.com	12%
FirstLast@cingulatetherapeutics.com	JohnDoe@cingulatetherapeutics.com	4%
FMiddleLast@cingulatetherapeutics.com	JMichaelDoe@cingulatetherapeutics.com	4%
FLast@cingulate.com	JDoe@cingulate.com	91%
FMiddleLast@cingulate.com	JMichaelDoe@cingulate.com	9%

Frequently Asked Questions

Where is Cingulate Therapeutics's headquarters located?

Cingulate Therapeutics's main headquarters is located at 1901 W. 47th Place, Suite 310 Kansas City, Kansas 66205, US. The company has employees across 1 continents, including North America.

What is Cingulate Therapeutics's phone number?

You can contact Cingulate Therapeutics's main corporate office by phone at

+1-862-260-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cingulate Therapeutics's stock symbol?

Cingulate Therapeutics is a publicly traded company; the company's stock symbol is CING.

What is Cingulate Therapeutics's official website and social media links?

Cingulate Therapeutics's official website is cingulate.com and has social profiles on LinkedIn.

What is Cingulate Therapeutics's NAICS code?

Cingulate Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cingulate Therapeutics have currently?

As of October 2025, Cingulate Therapeutics has approximately 20 employees across 1 continents, including North America. Key team members include Chief Legal Officer: N. P.Chief Medical Officer: M. B.Chief Science Officer: R. S.. Explore Cingulate Therapeutics's employee directory with LeadIQ.

What industry does Cingulate Therapeutics belong to?

Cingulate Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Cingulate Therapeutics use?

Cingulate Therapeutics's tech stack includes Module FederationWeb VitalsDataTablescore-jsPHPHSTSX-Content-Type-OptionsGoogle Analytics.

What is Cingulate Therapeutics's email format?

Cingulate Therapeutics's email format typically follows the pattern of FLast@cingulatetherapeutics.com. Find more Cingulate Therapeutics email formats with LeadIQ.

When was Cingulate Therapeutics founded?

Cingulate Therapeutics was founded in 2012.

Cingulate Therapeutics

Q: What is Cingulate Therapeutics's official website and social media links?

Cingulate Therapeutics's official website is cingulate.com. Cingulate Therapeutics has social profiles on LinkedIn.

Q: How many employees does Cingulate Therapeutics have currently?

Cingulate Therapeutics has approximately 20 employees.

Q: What technology does Cingulate Therapeutics use?

Cingulate Therapeutics's tech stack includes Modernizr, jQuery, MySQL, Web Vitals, Google Fonts API.

Pharmaceutical ManufacturingUnited States11-50 Employees

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.  
 
We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.  
 
With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.